Overall survival, event-free survival, and relapse rate of AML and MDS patients. AML/MDS patients (n = 81): OS (A) and EFS (B) according to disease status at time of HCT (advanced vs early), P values: univariate analysis (Cox proportional hazards regression model), (C) cumulative incidence of relapse according to disease status at time of HCT (advanced vs early).